StonvexLoading…
StonvexStonvexStonvexCore line items from CPBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $20.54M | $13.37M | $6.58M | $24.70M |
Operating Income | $3.82M | $2.34M | $1.23M | $4.52M |
Net Income | $3.04M | $1.87M | $988.00K | $3.65M |
EPS (Diluted) | $0.80 | $0.49 | $0.26 | $0.96 |
Total Assets | $535.74M | $510.00M | $500.88M | $508.70M |
Total Liabilities | $447.98M | $423.82M | $416.23M | $425.37M |
Cash & Equivalents | $28.11M | $8.89M | $7.92M | $28.68M |
Free Cash Flow OCF − CapEx | $2.35M | $122.00K | $-766.00K | $-3.07M |
Shares Outstanding | 4.21M | 4.22M | 4.22M | 4.23M |